Tomaszewski, Erin L.
Moise, Pierre
Krupnick, Robert N.
Downing, Jared
Meyer, Margaret
Naidoo, Shevani
Holmstrom, Stefan
Funding for this research was provided by:
This study was funded by Astellas Pharma, Inc. and Medivation, Inc. (which was acquired by Pfizer, Inc. in September 2016), the co-developers of enzalutamide.